Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Fitch affirms Akelius BBB rating but changes outlook to negative

On December 12, Fitch Ratings revised the outlook on Akelius’ credit rating to negative from stable. Akelius’ issuer credit rating has been affirmed at BBB and the senior unsecured rating is affirmed BBB+. The negative outlook reflects the recently announced extra dividend on class A ordinary shares. CEO, Ralf Spann - Akelius continues to be in a very strong financial position, following the guarantee from the owner.  Berlin, 2023-12-12 Ralf SpannCEO+49 173 643 65 90ralf.spann@akelius.de This information is information that Akelius Residential Property AB (publ)

OBSERVE MEDICAL ASA – The Company has received subscriptions for offer shares raising gross proceeds in the rights issue of more than NOK 18,000,000.20 in cash

Oslo, 12 December 2023: Reference is made to the stock exchange announcements published by Observe Medical ASA (the "Company") regarding the rights issue of minimum 69,230,770 new shares and maximum 211,538,461 new shares in the Company (the "Offer Shares"), each with a nominal value of NOK 0.26, at a subscription price of NOK 0.26 per Offer Share (the "Rights Issue"). As previously announced, completion of the Rights Issue is subject to (i) the Company raising gross proceeds in the Rights Issue of minimum NOK 18,000,000.20 in cash and (ii) each of the lenders ("Lenders") (listed in

Avida Finans AB (publ) publishes bond prospectus and applies for admission to trading of bonds on Nasdaq Stockholm

Avida Finans AB (publ) (the "Company") issued on 27 October 2023 subordinated tier 2 bonds in an amount of SEK 250,000,000. The bonds carry a floating interest rate of STIBOR 3m + 9.25 per cent. per annum and mature on 27 January 2034. The Company will apply for admission to trading of the bonds on the Corporate Bond list at Nasdaq Stockholm. The bonds will be admitted to trading at Nasdaq Stockholm as soon as possible. In connection with this, the Company has prepared a prospectus. The prospectus has been approved by, and registered with, the Swedish Financial Supervisory Authority

Changes in Formpipe's organization.

Formpipe is taking several steps to further strengthen its market position. From January 1, 2024 the business areas for the Swedish and Danish public sectors will be merged into one. Thomas à Porta is appointed Executive Vice President, Head of the new Business Area Public. Michael Rogers is appointed Executive Vice President, Head of the Private business area."I intend to lead Formpipe into a new phase of growth. I see great advantages in one organization for our business that target the public sector. The business logic is the same across the national borders. The merger creates clarity

Stora Enso commits to net-zero carbon emissions

STORA ENSO OYJ INVESTOR NEWS 12 December 2023 at 17:00 EETStora Enso commits to reach net-zero carbon emissions by 2040 by becoming a signatory of The Climate Pledge.   Committing to net-zero emissions by signing The Climate Pledge is a logical step for Stora Enso in its long-term ambition to become net carbon positive, and to offer 100% regenerative products and solutions by 2050. Stora Enso remains committed to deliver on its existing 2030 target to reduce absolute Scope 1, 2 and 3 emissions by 50% from the 2019 baseline. This target is aligned with the 1.5-degree scenario and is

100 percent Frem becomes SPACEMANN

ASSMANN takes over leading English manufacturer of room-in-room systemsASSMANN Büromöbel GmbH & Co. KG has completed its takeover of the British Frem Group Screens Limited. The Melle-based family business acquired the remaining 26 percent of shares in one of England’s leading manufacturers of room-in-room systems at the beginning of December. Now renamed SPACEMANN, the company will operate as an independent development and production facility with a clear differentiation to the sales subsidiary ASSMANN Office Furniture Ltd. All of the approximately 40 employees have kept their jobs. “Not

Neonode Launches Sharpened Strategy with Full Focus on Its Licensing Business

STOCKHOLM, SWEDEN, December 12, 2023 — Neonode Inc. (NASDAQ: NEON) today announces a new, sharpened strategy with full focus on its licensing business. Consequently, Neonode will phase out its Touch Sensor Module (“TSM”) product business through licensing of the TSM technology to strategic partners or outsourcing.Neonode has been successful in licensing technology historically and the management team sees the largest potential for future growth and profitability in this area.  The focus will be on licensing of the advanced MultiSensing® platform for driver and in-cabin monitoring and the

Report from the extraordinary general meeting of Cereno Scientific AB (publ)

Today, December 12, 2023, Cereno Scientific AB (publ) held an extraordinary general meeting at MAQS Advokatbyrå's premises at Östra Hamngatan 24 in Gothenburg, Sweden. Chairman of the general meeting was attorney Eric Ehrencrona from MAQS Advokatbyrå.The following main resolutions were resolved at the general meeting: Resolution on adjustment of the terms and conditions for the warrants of series 2023/2026:1 and 2023/2026:4, respectively, and the agreements regarding the respective incentive program The general meeting resolved, in accordance with the board of director’s proposal, to

Fredrik Emilson new CEO of Enviro

Scandinavian Enviro Systems (publ) ("Enviro" or the "Company") has hired Fredrik Emilson, former CEO of Höganäs AB, as the company's new Chief Executive Officer. Emilson takes office in February 2024 at the same time as current CEO Thomas Sörensson moves to a role as senior advisor. Fredrik Emilson. Fredrik Emilson comes most recently from Höganäs AB, where he worked since 2010 and from 2017 as CEO. During his time at Höganäs AB, Fredrik also held the role of European manager followed by the role of responsible for Asia. Höganäs is the world leader in metal powder solutions

John Mattson publishes the preliminary outcome of the rights issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER COUNTRY OR JURISDICTION TO WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR REGULATIONS OR WOULD REQUIRE THE PREPARATION OR REGISTRATION OF ADDITIONAL DOCUMENTATION OR REQUIRE ANY OTHER ACTION TO BE TAKEN, IN ADDITION TO THE REQUIREMENTS OF SWEDISH LAW. THIS PRESS RELEASE IS NOT A PROSPECTUS BUT AN ANNOUNCEMENT IN CONNECTION WITH THE PLANNED NEW ISSUE OF

Atrium Ljungberg changes its dividend policy and strengthens its execution power of the project portfolio

Atrium Ljungberg will conduct its business with low financial risk-taking in order to enable the implementation of profitable and value-creating urban development projects. In the light of increased investment pace in urban development projects, the Board of Directors believes that a lower dividend payout ratio will be appropriate and has therefore decided on a new dividend policy.The company has a project portfolio corresponding to an investment volume of approximately SEK 40 billion in already owned land or obtained land allocations. The investments, with implementation over the next 10–

Stayble Therapeutics Phase IIb data support effectiveness in treating herniated discs

Stayble Therapeutics AB ("Stayble" or the "Company") today presents further analyses from the Phase IIb study on degenerative disc disease (DDD) and its impact on the Company's other project on lumbar disc herniation (LDH). In patients who received the higher dose of STA363, a statistically significant difference was observed in disc intensity and disc height, which are clear signs of reduced disc volume. These effects should lead to a decrease in the volume of the herniation and, thus, pain reduction in patients with herniated discs.In the ongoing analyses of results from the DDD study, a

The district court approves YA Holding’s subsidiary YrkesAkademin AB’s request for an extension of the restructuring

As announced through a press release on 1 December 2023, YA Holding AB’s (publ) (“YA Holding”) wholly owned subsidiary YrkesAkademin AB submitted a request to the district court regarding an extension of the ongoing company restructuring that same date. YA Holding now announces that Falu District Court today approved YrkesAkademin AB’s request for an extension of the company reconstruction with an additional three (3) months up to and including 4 March 2024. For more information on the background to the company restructuring, press here 

The sale of YIT’s renewable energy business to Eolus completed

YIT Corporation Investor News 12 December 2023 at 3:15 p.m.The sale of YIT's renewable energy business, YIT Energy Oy, to Eolus Vind Ab has been completed. YIT announced the sale on 5 December 2023. The transaction consists of a fixed and a variable purchase price. The fixed purchase price is EUR 25 million, which will be paid in three instalments. The first instalment of EUR 10 million has been paid at closing and EUR 15 million will be paid in two instalments during 2024 and 2025. The variable purchase price is defined based on project sales and completed projects and it amounts to

OBSERVE MEDICAL ASA – Major shareholders have converted their loans in the rights issue and/or entered into amendment agreements

Oslo, 12 December 2023: Reference is made to the stock exchange announcements published by Observe Medical ASA (the "Company") regarding the rights issue of minimum 69,230,770 new shares and maximum 211,538,461 new shares in the Company (the "Offer Shares"), each with a nominal value of NOK 0.26, at a subscription price of NOK 0.26 per Offer Share (the "Rights Issue"). As previously announced, completion of the Rights Issue is subject to (i) the Company raising gross proceeds in the Rights Issue of minimum NOK 18,000,000.20 in cash and (ii) each of the lenders ("Lenders") (listed in

Form 8.3 - Hotel Chocolat Group plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.         KEY INFORMATION (a) Full name of discloser: Magnetar Capital Partners LP(b) Owner or controller of interests and shortpositions disclosed, if different from 1(a):    The naming of nominee or vehicle companies isinsufficient.  For a trust, the trustee(s),settlor and beneficiaries must be named.(c) Name of offeror/offeree in relation to whose Hotel

Report from Extraordinary General Meeting of Embellence Group AB (publ)

Embellence Group AB (publ) held on Friday 8 December 2023 an extraordinary general meeting at MAQS Advokatbyrå’s premises at Stureplan 19 in Stockholm, Sweden. Fredrik Brusberg, associate at MAQS Advokatbyrå, was elected as chairman of the general meeting.The following main resolutions were resolved upon at the general meeting: Election of board of directors and the chairman of the board of directorsThe general meeting resolved, in accordance with a shareholder group’s proposal, to re-elect the existing board members Karin Dennford, Anneli Kansbod, Henrik Nyqvist, and Christina Ståhl

Biosergen’s Partner Alkem Laboratories Submits Clinical Trial Application for First Patient Study with BSG005 in Invasive Fungal Infections in India as a Rescue Therapy

Stockholm, Sweden – December 12, 2023 – Biosergen AB (“Biosergen” or the “Company”), a clinical-stage biotech company specializing in the development of innovative antifungal therapies, is pleased to announce that the Company’s partner, Alkem Laboratories Limited (“Alkem”), has submitted a Clinical Trial Application to the Central Drugs Standard Control Organization (CDSCO) in India. The application pertains to the initiation of the first patient study for BSG005, Biosergen’s leading antifungal drug candidate, a clinical trial designed to address unmet medical needs in invasive fungal

SUM IT UP #5 at MITP: Celebrating Milestones in Moldova's Tech Evolution

Chisinau, Moldova - Moldova Innovation Technology Park  (MITP.md) recently marked a significant milestone with the conclusion of its 5th SUM IT UP event. This event showcased the dynamic growth and significant advancements within Moldova's tech ecosystem, affirming MITP's crucial role in shaping the nation's technological landscape.Dumitru Alaiba, Minister of Economic Development and Digitalization, opened the event with a vision of extending guarantees for the IT Park for another 12 years. He expressed hope for IT integration across all sectors of the economy

Stora Enso’s fourth quarter 2023 impairment test results

STORA ENSO OYJ INVESTOR NEWS 12 December 2023 at 14:45 EETStora Enso will record non-cash impairments of approximately EUR 514 million in its IFRS operating result in the fourth quarter of 2023. The impairments will be reported as an item affecting comparability (IAC). Including the estimated positive tax effect of EUR 65 million, the net result impact will be approximately EUR 449 million negative.   The impairment charges are allocated between the segments as follows:  EUR million Goodwill Fixed assets Total impairmentPackaging Materials 26 355

Polar releases “2023: Reflected” report, showing physical activity, sports, and sleep trends

Polar Electro, the world leader in personal guidance for fitness, sport, and health, today announced the release of its “2023: Reflected” report, revealing global activity, sports, and sleep trends. With walking emerging as the second most tracked activity globally, this year’s findings confirm the commitment to moderate intensity physical activity as a form of staying active and nurturing personal wellness.  Walking makes up nearly 16% of all tracked workouts by Polar users. On average, users in all age groups log 2.73 miles (4.4 kilometers) per walk in 65 minutes on average, people

Aixia takes new order with existing customer, value SEK 3.8 million

Mölndal                                                                                                                      2023-12-12 Aixia takes an order regarding data management with an existing customer, the customer who is a technology company and an innovator of cloud services to manage product flows in e-commerce, logistics and industry invests in a new data management solution to expand and ensure future requirements and needs from the market. The order is worth SEK 3.8 million and will be delivered in December 2023 Aixia thanks for the trust. It's a lot of fun to be able

STOREBRAND ASA: Agenda - Capital Markets Day 2023

Storebrand hosts a virtual Capital Markets Day tomorrow December 13 at 10:00-13:00 CET. The presentation will be held by Storebrand's executive management with a focus on the company's growth strategy and ambitions. An update on the implications from higher interest rates, the balance sheet and solvency position, and capital and cash generation will also be provided. The agenda is as follows: +----------------------------------------+---------------------+| Topic | Presenter |+----------------------------------------+---------------------

Innovative Funding Solutions Explored at "Alternative Funding for Startups and SMEs" Conference in Moldova

Chisinau, December 09, 2023 - Identifying funding sources and exploring options for business and startup development were the main topics of the conference "Alternative Funding for Startups and SMEs" held in Chisinau. The conference covered topics such as crowdfunding, business angels, venture capital funds, equity funding, funding programs, and grants—additional financing options for entrepreneurs at the beginning of their journey who lack fixed assets or guarantees to obtain the necessary funds. The event brought together officials, entrepreneurs, startup founders, investors, and

There are no items matching the current filter
There are no more items matching the current filter
Back to top